A Macrophage/Monocyte‐Related Four‐Gene Signature for Prognostic Assessment of Uveal Melanoma: BTBD6, C2CD4B, CCL24, and S100A4
Yuhui Yu, Mengya Wang, Bin Zhao · 2026
Read A Macrophage/Monocyte‐Related Four‐Gene Signature for Prognostic Assessment of Uveal Melanoma: BTBD6, C2CD4B, CCL24, and S100A4 by Yuhui Yu, Mengya Wang, Bin Zhao (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13269842.txt.
Description
Yuhui Yu, Mengya Wang, and Bin Zhao published a journal article in 2026 building a four-gene risk score for uveal melanoma, a highly malignant eye tumor. Immune cells called macrophages and monocytes in the tumor's surroundings help it escape and spread. Cancer atlas data and single-cell profiles were used to find their key genes.
Six cell groups were mapped in tumor samples, with macrophage and monocyte cells prominent. The risk score combined BTBD6, C2CD4B, CCL24, and S100A4. Patients with high scores had poorer survival, more monocyte-lineage and T-cell entry, and higher immune checkpoint gene activity. High scores also went with stronger sensitivity to eight chemotherapy drugs in the analysis. The authors offer the score for prognosis work.
Catalog record
| CREATOR | Yuhui Yu, Mengya Wang, Bin Zhao |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 30495 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |